These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 17978312)
21. [IgA nephropathy. Significance of immunoglobulin A glycosylation in pathogenesis and clinical presentation]. Matousovic K; Konecný K; Mĕstecký J; Tomana M; Novák J Cas Lek Cesk; 2002 Nov; 141(23):729-34. PubMed ID: 12650029 [TBL] [Abstract][Full Text] [Related]
22. Compositional similarity between immunoglobulins binding to asialo-, agalacto-IgA1-Sepharose and those deposited in glomeruli in IgA nephropathy. Takatani T; Iwase H; Itoh A; Nakamura I; Hayashi M; Sakamoto H; Kamata K; Kobayashi Y; Hiki Y; Okamoto M; Higashihara M J Nephrol; 2004; 17(5):679-86. PubMed ID: 15593035 [TBL] [Abstract][Full Text] [Related]
23. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. Smith AC; Molyneux K; Feehally J; Barratt J J Am Soc Nephrol; 2006 Dec; 17(12):3520-8. PubMed ID: 17093066 [TBL] [Abstract][Full Text] [Related]
24. Hemizygous Fabry disease associated with IgA nephropathy: a case report. Shimohata H; Yoh K; Takada K; Tanaka H; Usui J; Hirayama K; Kobayashi M; Yamagata K J Nephrol; 2009; 22(5):682-4. PubMed ID: 19810002 [TBL] [Abstract][Full Text] [Related]
25. Enzymatically deglycosylated human IgA1 molecules accumulate and induce inflammatory cell reaction in rat glomeruli. Sano T; Hiki Y; Kokubo T; Iwase H; Shigematsu H; Kobayashi Y Nephrol Dial Transplant; 2002 Jan; 17(1):50-6. PubMed ID: 11773462 [TBL] [Abstract][Full Text] [Related]
26. Specific tissue distribution of megsin, a novel serpin, in the glomerulus and its up-regulation in IgA nephropathy. Inagi R; Miyata T; Suzuki D; Toyoda M; Wada T; Ueda Y; Izuhara Y; Sakai H; Nangaku M; Kurokawa K Biochem Biophys Res Commun; 2001 Sep; 286(5):1098-106. PubMed ID: 11527413 [TBL] [Abstract][Full Text] [Related]
27. Mesangial IgA deposits. Morel-Maroger L; Mery JP; Robert CL; Richet G Perspect Nephrol Hypertens; 1973; 1 Pt 1():301-4. PubMed ID: 4620920 [No Abstract] [Full Text] [Related]
28. Mesangial autoantigens in IgA nephropathy: matrix synthesis and localization. Darvill AM; Ballardie FW J Lab Clin Med; 2006 Jun; 147(6):301-9. PubMed ID: 16750668 [TBL] [Abstract][Full Text] [Related]
29. Detection of alpha(beta)-N-acetyl-D-galactosamine-binding sites in kidney--relation to Henoch-Schönlein-associated IgA nephropathy. Sedivá A; Stejskal J; Bartůnková J; Smetana K; Gabius HJ Folia Biol (Praha); 1999; 45(4):147-50. PubMed ID: 10732728 [TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of IgA deposits on the glomerular capillary wall in IgA nephropathy]. Yoshimura M; Kida H; Hirahara K; Katagiri M; Takeda S; Yokoyama H; Koshino Y; Tomosugi N; Abe T; Hattori N Nihon Jinzo Gakkai Shi; 1985 Nov; 27(11):1495-502. PubMed ID: 3831467 [No Abstract] [Full Text] [Related]
31. In vitro solubilization of glomerular immune deposits after incubation with human IgG and IgA in membranous and IgA nephropathy. Cirami C; Finato V; Andreini B; Bianchi AM; Panichi V; Montagnani E; Parrini M; Gattai V; Casarosa L; Palla R Clin Nephrol; 1993 Sep; 40(3):185. PubMed ID: 8403576 [No Abstract] [Full Text] [Related]
32. O-linked oligosaccharide on IgA1 hinge region in IgA nephropathy. Fundamental study for precise structure and possible role. Hiki Y; Horii A; Iwase H; Tanaka A; Toda Y; Hotta K; Kobayashi Y Contrib Nephrol; 1995; 111():73-84. PubMed ID: 7758349 [No Abstract] [Full Text] [Related]
33. Microbial IgA protease removes IgA immune complexes from mouse glomeruli in vivo: potential therapy for IgA nephropathy. Lamm ME; Emancipator SN; Robinson JK; Yamashita M; Fujioka H; Qiu J; Plaut AG Am J Pathol; 2008 Jan; 172(1):31-6. PubMed ID: 18165266 [TBL] [Abstract][Full Text] [Related]
34. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy. Shimozato S; Hiki Y; Odani H; Takahashi K; Yamamoto K; Sugiyama S Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603 [TBL] [Abstract][Full Text] [Related]
35. [Immunoelectron microscopic analysis of intraglomerular deposits in IgA-dominant immunotactoid glomerulopathy]. Kawashima M; Horita S; Nakayama H; Honda K; Uchida K; Nitta K; Yumura W; Nihei H Rinsho Byori; 2002 Nov; 50(11):1085-9. PubMed ID: 12491608 [TBL] [Abstract][Full Text] [Related]
36. The glomerular response to IgA deposition in IgA nephropathy. Moura IC; Benhamou M; Launay P; Vrtovsnik F; Blank U; Monteiro RC Semin Nephrol; 2008 Jan; 28(1):88-95. PubMed ID: 18222350 [TBL] [Abstract][Full Text] [Related]
37. Tissue distribution and biological activities of immune complexes are determined by their size and composition. Matousovic K; Novak J; Julian BA; Mestecky J Nephrol Dial Transplant; 2010 Mar; 25(3):1007. PubMed ID: 19914998 [No Abstract] [Full Text] [Related]
38. Modulation of mesangial cell reactivity by aberrantly glycosylated IgA. Amore A; Coppo R Nephron; 2000 Nov; 86(3):255-9. PubMed ID: 11096280 [No Abstract] [Full Text] [Related]
39. IgA nephropathy: immune mechanisms beyond IgA mesangial deposition. Rifai A Kidney Int; 2007 Aug; 72(3):239-41. PubMed ID: 17653232 [TBL] [Abstract][Full Text] [Related]
40. Clearance kinetics and fate of macromolecular IgA in patients with IgA nephropathy. Rifai A; Schena FP; Montinaro V; Mele M; D'Addabbo A; Nitti L; Pezzullo JC Lab Invest; 1989 Oct; 61(4):381-8. PubMed ID: 2796287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]